US3396409A - Artificial heart valve - Google Patents

Artificial heart valve Download PDF

Info

Publication number
US3396409A
US3396409A US512695A US51269565A US3396409A US 3396409 A US3396409 A US 3396409A US 512695 A US512695 A US 512695A US 51269565 A US51269565 A US 51269565A US 3396409 A US3396409 A US 3396409A
Authority
US
United States
Prior art keywords
ring
valve
guide members
closure
closure member
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US512695A
Inventor
Melrose Denis Graham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
National Research Development Corp UK
Original Assignee
Nat Res Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nat Res Dev filed Critical Nat Res Dev
Application granted granted Critical
Publication of US3396409A publication Critical patent/US3396409A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Images

Classifications

    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16K—VALVES; TAPS; COCKS; ACTUATING-FLOATS; DEVICES FOR VENTING OR AERATING
    • F16K15/00—Check valves
    • F16K15/02—Check valves with guided rigid valve members
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2403—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members
    • A61F2/2406—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with pivoting rigid closure members without fixed axis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2409—Support rings therefor, e.g. for connecting valves to tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
    • A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
    • A61F2/02—Prostheses implantable into the body
    • A61F2/24—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body
    • A61F2/2421—Heart valves ; Vascular valves, e.g. venous valves; Heart implants, e.g. passive devices for improving the function of the native valve or the heart muscle; Transmyocardial revascularisation [TMR] devices; Valves implantable in the body with non-pivoting rigid closure members
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/7722—Line condition change responsive valves
    • Y10T137/7837—Direct response valves [i.e., check valve type]
    • Y10T137/7898—Pivoted valves
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T137/00—Fluid handling
    • Y10T137/7722—Line condition change responsive valves
    • Y10T137/7837—Direct response valves [i.e., check valve type]
    • Y10T137/7904—Reciprocating valves
    • Y10T137/7908—Weight biased
    • Y10T137/7909—Valve body is the weight
    • Y10T137/7913—Guided head

Definitions

  • stop means are provided on the ring-member for engagement with said guide members.
  • an implanted member is initially sutured to the surrounding living tissue but it is preferable to take advantage of the natural fibrosis which can occur between living tissue and a porous material.
  • the ring-member by which location of the valve in a valve orifice is effected therefore has the outward facing surface thereof channelled in which channelled surface a biologically inert porous material is positioned.
  • the heart tissue surrounding the artificial valve grows by fibrosis into the porous material thereby securing the ring-member in the valve orifice.
  • the shaping of the aforesaid guide members for abutment with the channelled ring-member will be governed by any restrictions imposed by the structure of the heart surrounding the inlet side of the valve.
  • the guide members therefore may, for a restricted environment, be of rod like form of minimum length and having their free ends shaped to abut the ring-member. Where the environment imposes no such restrictions the guide members may be of arcuate form, the concave side of which members being adjacent the ring-member, the concavity and length of which members being dictated by their position on the 3,396AW Patented Aug. 1 3, 1968 surface of the closure member and therefore the function which the member has to perform.
  • the valve closure member is preferably though not essentially comprised of a rigid material, although it will be apparent that for a reliable valve seal, by the engagement of one face of the closure member with a seating surface of the channelled ring member, at least one of these two members must be of substantially rigid form. It is therefore preferable that the means for securing the valve in the valve orifice is of a substantially rigid form.
  • the word lenticular is used to describe the shape of the valve member indicates that the member has the shape of a bi-convex lens and which preferably has the cross-section of that of a spherical bi-convex lens; the perimeter of the member however need not necessarily be circular.

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Transplantation (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Mechanical Engineering (AREA)
  • Prostheses (AREA)

Description

Aug. 13, 1968 D. G. MELROSE ARTIFICIAL HEART VALVE 2 Sheets-Sheet 1 Filed Dec.
s- 3, 1968 D. G. MELROSE 3,396,409
ARTIFIC IAL HEART VALVE v Filed Dec. 9, 1965 2 Sheets-Sheet United States Patent 0 3,396,409 ARTIFICIAL HEART VALVE Denis Graham Melrose, London, England, assignor to National Research Development Corporation, London, England, a British company Filed Dec. 9, 1965, Ser. No. 512,65 Claims priority, application Great Britain, Dec. 31, 1964, 53,104/64 12 Claims. (Cl. 3-1) This invention relates to an improved form of a oneway valve suitable for use as an artificial heart valve in surgical heart prosthesis.
Mitral valve deficiency is one characteristic of congenital or acquired heart disorders, such deficiency being manifest in the inability of the valve to operate strictly as a one-way valve which is its normal and essential function. In such a case therefore it is necessary to replace the deficient valve with an artificial one-way valve. Examples of heart valve incompetence are known, where the natural valve system operates in such a restricted environment that artificial heart valves hitherto available may not be successfully used as a replacement.
According to the invention there is provided a one-way fluid control valve adapted for actuation by a reversal of fluid flow which comprises, a lenticular-shaped valve closure member having at least two well-spaced tapering guide members projecting from one of its faces, at least one guide member projecting further than another, and a ring-member which surrounds at least part of said guide members the surface of the ring-member adjacent said one face of the closure member being adapted for engagement with a seating portion of said face so as, in operation, to effect closure of the valve, said guide members being so shaped as to provide by abutment with said ring-member limitation of movement of said closure member away from said seating portion of said ring member.
To restrict rotation of the valve closure member relative to the ring-member stop means are provided on the ring-member for engagement with said guide members.
According to one embodiment of the invention said stop means is formed by a recession of the inward facing surface of the ring-member, said longer guide members b ing located by said recess.
According to another embodiment of the invention, said stop means comprises an abutment positioned on the inward facing surface of said ring-member, the abutment be ing located between two of said guide members.
In surgical prosthesis such an implanted member is initially sutured to the surrounding living tissue but it is preferable to take advantage of the natural fibrosis which can occur between living tissue and a porous material. The ring-member by which location of the valve in a valve orifice is effected therefore has the outward facing surface thereof channelled in which channelled surface a biologically inert porous material is positioned. The heart tissue surrounding the artificial valve grows by fibrosis into the porous material thereby securing the ring-member in the valve orifice.
The shaping of the aforesaid guide members for abutment with the channelled ring-member will be governed by any restrictions imposed by the structure of the heart surrounding the inlet side of the valve. The guide members therefore may, for a restricted environment, be of rod like form of minimum length and having their free ends shaped to abut the ring-member. Where the environment imposes no such restrictions the guide members may be of arcuate form, the concave side of which members being adjacent the ring-member, the concavity and length of which members being dictated by their position on the 3,396AW Patented Aug. 1 3, 1968 surface of the closure member and therefore the function which the member has to perform.
The valve closure member is preferably though not essentially comprised of a rigid material, although it will be apparent that for a reliable valve seal, by the engagement of one face of the closure member with a seating surface of the channelled ring member, at least one of these two members must be of substantially rigid form. It is therefore preferable that the means for securing the valve in the valve orifice is of a substantially rigid form. The word lenticular is used to describe the shape of the valve member indicates that the member has the shape of a bi-convex lens and which preferably has the cross-section of that of a spherical bi-convex lens; the perimeter of the member however need not necessarily be circular.
The choice of materials from which the valve components may be prepared is governed by two requirements. The first and most important requirement being that the material must essentially be of a biologically inert nature; the second requirement is that the material must be capable of being worked or moulded to produce the required shapes of the valve components and must in certain instances be capable of being produced in a substantially rigid form. Examples of such materials suitable for the components of the valve are the metals, stainless steel, platinum and titanium and the synthetic materials, polypropylene, polyvinyl alcohol, polytetrafiuoroethylene and polystyrene.
In a further embodiment of the invetnion therefore the means positioned in the channel of the ringmember to secure the ring-member to the surrounding heart tissue may comprise a stainless steel ring encased in a biologically inert porous sponge material.
In a further embodiment of the invention said securing means comprises a polytetrafiuoroethylene ring encased in a biologically inert porous sponge material. In a preferred embodiment of the invetnion said biologically inert porous sponge material comprises polypropylene mesh.
One example of an artificial heart valve in accordance with the invention will now be described with reference to the accompanying drawings in which FIGURES 1, 2, 4 and 5 show side elevations in section of two alternative forms of an artificial mitral valve in the closed and open position respectively, and FIGURES 3 and 6 show perspective views respectively of such valves.
In FIGURES 1, 2 and 3 there is shown a one-way artificial heart valve which comprises a substantially rigid ring-member 1 having a lenticular-shaped valve closure member 2 positioned below the ring-member 1. An annular seating surface 3 is positioned on the lower and inward facing surface of the ring member 1 against which the upper surface 4 of the closure member 2 contacts to effect a fluid tight seal on valve closure. Guide members 5 and 6 are positioned on the upper surface of the closure member 2 and depend freely through the ring member 1 and are shaped at their upper ends to abut the ringmember 1 to limit downward movement of the valve closure member 2. Guide member 5 is substantially longer than guide member 6 in order that the valve closure member 2 with the valve in the fully open position can assume the asymmetrical position as shown. A stainless steel ring is located in a groove 8 on the periphery of the ring member 1 and is itself encased in a biologically inert porous material 9 which porous material 9 engages with the surrounding tissues when inserted in a heart valve orifice and enables fibrosis to occur between the tissue and the porous material. A recession It) on the inward facing surface of the ring-member is provided for receiving guide member 5 to restrict rotation of the valve closure member 2 relative to said ring member.
In FIGURES 4, 5 and 6 there is shown a one-way artificial heart valve which comprises a substantially rigid ring-member 11 having a lenticular-shaped valve closure member 12 positioned below the ring-member 11. An annular seating surface 13 is positioned on the lower and inward facing surface of the ring-member 11 against which the upper surface 14 of the closure member 12 contacts to effect a fluid tight seal on valve closure. Guide members 15 and 16 are positioned on the upper surface of the closure member 12 and depend freely through the ringmember 11 and are shaped at their upper ends to abut the ring-member 11 to limit downward movement of the valve closure member 12. Guide member 15 is substantially shorter than guide members 16 in order that the valve closure member 12 with the valve in the fully open position can assume the asymmetrical position as shown. A polytetrafluorethylene ring 17 is located in a groove 18 on the periphery of the ring-member 11 and is itself encased in a. biologically inert porous material 19 which porous material 19 engages with the surrounding tissues when inserted in a heart valve orifice and enables fibrosis to occur between the tissue and the porous material. An abutment 20 is positioned on the inward facing surface of the ring-member between two of the guide members 16 to restrict rotation of the valve closure member 12 relative to said ring-member.
It will be apparent from the construction of the artificial heart valve in accordance with the invention that the valve will in operation have an opening action directing the fiow of blood into an area where the flow is most required or at least most able to accommodate it. Furthermore it will be seen that although the positioning of the guide members is arranged primarily to produce a flow directing effect their positioning and shape is also effective in producng maximum scouring action by the blood flow in passage through the valve, thereby serving to minimize blood clot formation on the surfaces of the valve members.
I claim:
1. A one-way fluid control valve adapted for actuation by a reversal of fluid flow which comprises, a lenticularshaped valve closure member having at least two welltapering guide members projecting outwardly from one of its faces, at least one guide member projecting further than another, and a ring-member which surrounds at least part of said guide members the surface of the ring-member adjacent said one face of the closure member being adapted for engagement with a seating portion of said face so as, in operation, to effect closure of the valve, said guide members being so shaped as to provide by abutment with said ring-member limitation of movement of said closure member away from said seating portion of said ring-member.
2. A one-way valve according to claim 1, wherein stop means is provided for restricting rotation of said closure member relative to said ring-member.
3. A one-way valve according to claim 2, wherein said stop means is formed by a recession of the inward facing surface of said ring-member, at least one of said longer guide members being located by said recess.
4. A one-way valve according to claim 2, wherein said stop means comprises an abutment positioned on the inward facing surface of said ring-member, said abutment being located between said guide members.
5. A one-way artificial heart valve according to claim 2, wherein the outward facing surface of said ring-member is channelled.
6. A one-way artificial heart valve according to claim 5, wherein there is positioned in the channel of said ringmember securing means for effecting location and securement of said ring-member in a heart valve orifice.
7. A one-way artificial heart valve according to claim 6, wherein said securing means comprises a stainless steel ring encased in a biologically inert porous sponge material.
8. A one-way artificial heart valve according to claim 6, wherein said securing means comprises a polytetrafiuoroethylene ring encased in a biologically inert porous sponge material.
9. A one-way artificial heart valve according to claim 8, wherein said biologically inert porous sponge material is comprised of a polypyropylene mesh.
10. A one-way artificial heart valve according to claim 9, wherein the valve closure member, guide members and channelled ring-member are comprised of polypropylene.
11. A one-way artificial heart valve adapted for actuation by a reversal of blood-flow which comprises, a lenticular-shaped valve closure member having three wellspaced tapering guide members projecting outwardly from one of its faces one of said guide members. projecting further than said other two guide members, a ring-member which surrounds at least part of said three guide members, the surface of the ring-member adjacent said one face of the closure member being adapted for engagement with a seating portion of said face so as, in operation, to effect closure of the valve, said guide members being so shaped as to provide by abutment with said ring-member limitation of movement of said closure member away from said seating portion of said ring-member, a channel-shaped housing formed in the outward facing surface of said ringmember and having located therein a polytetrafluoroethylene ring encased in polypropylene mesh, and stop means for restricting rotation of said closure member relative to said ring-member formed by a recession of the inward facing surface of said ring member said longer guide member being located by said recess.
12. A one-way artificial heart valve adapted for actuation by a reversal of blood-flow which comprises, a lenticular-shaped valve closure member having three wellspaced tapering guide members projecting outwardly from one of its faces, two of said guide members projecting further than said other one guide member, a ring-member which surrounds at least part of said three guide members, the surface of the ring member adjacent said one face of the closure member being adapted for engagement with a seating portion of said face so as, in operation, to elfect closure of the valve, said guide members being so shaped as to provide by abutment with said ring-member limitation of movement of said closure member away from said seating portion of said ring member, a channel-shaped housing formed in the outward facing surface of said ring-member and having located therein a polytetrafluoroethylene ring encased in polypropylene mesh, and stop means for restricting rotation of said closure member relative to said ring-member, comprising an abutment positioned on the inward facing surface of said ring-member, said abutment being located between said two long guide members.
References Cited UNITED STATES PATENTS 2,564,023 8/1951 Miller 137533.17 3,294,116 12/1966 Tremeau 137-533 XR OTHER REFERENCES Prosthetic Replacement of the Mitral Valve, The Lancet, Nov. 24, 1962, p. 1087.
Pioneer Invents New Heart Valve, by Nate Haseltine, in The Washington Post, Nov. 24, 1963.
Evaluation of Two Prostheses for Total Replacement of the Mitral Valve, by F. S. Cross et al., The Journal of Thoracic and Cardiovascular Surgery, vol. 46, No. 6, December 1963, pp. 719-725.
RICHARD A. GAUDET, Primary Examiner.
R. L. FRINKS, Assistant Examiner.

Claims (1)

1. A ONE-WAY FLUID CONTROL VALVE ADAPTED FOR ACTUATION BY A REVERSAL OF FLUID WHICH COMPRISES, A LENTICULARSHAPED VALVE CLOSURE MEMBER HAVING AT LEAST TWO WELLTAPERING GUIDE MEMBERS PROJECTING OUTWARDLY FROM ONE OF ITS FACES, AT LEAST ONE GUIDE MEMBER PROJECTING FURTHER THAN ANOTHER, AND A RING-MEMBER WHICH SURROUNDS AT LEAST PART OF SAID GUIDE MEMBERS THE SURFACE OF THE RING-MEMBER ADJACENT SAID ONE FACE OF THE CLOSURE MEMBER BEING ADAPTED FOR ENGAGEMENT WITH A SEATING PORTION OF SAID FACE SO AS, IN OPERATION, TO EFFECT CLOSURE OF THE VALVE, SAID GUIDE MEMBERS BEING SO SHAPED AS TO PROVIDE BY ABUTMENT WITH SAID RING-MEMBER LIMITATION OF MOVEMENT OF SAID CLOSURE MEMBER AWAY FROM SAID SETTING PORTION OF SAID RING-MEMBER.
US512695A 1964-12-31 1965-12-09 Artificial heart valve Expired - Lifetime US3396409A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB53104/64A GB1073076A (en) 1964-12-31 1964-12-31 An improved artificial heart valve

Publications (1)

Publication Number Publication Date
US3396409A true US3396409A (en) 1968-08-13

Family

ID=10466655

Family Applications (1)

Application Number Title Priority Date Filing Date
US512695A Expired - Lifetime US3396409A (en) 1964-12-31 1965-12-09 Artificial heart valve

Country Status (4)

Country Link
US (1) US3396409A (en)
DE (1) DE1500177A1 (en)
GB (1) GB1073076A (en)
SE (1) SE310235B (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3513485A (en) * 1967-04-14 1970-05-26 Temple Univ School Of Medicine Prosthetic heart valve assembly
US3526906A (en) * 1965-11-05 1970-09-08 Lorraine Carbone Prosthetic implants made from carbonaceous materials
US3534411A (en) * 1967-10-05 1970-10-20 Donald P Shiley Cloth covered heart valve
US3656185A (en) * 1969-02-04 1972-04-18 Rhone Poulenc Sa Cardiac valvular support prosthesis
DE2313271A1 (en) * 1972-03-17 1973-09-27 Medical Inc ADDITIONAL ELEMENT FOR IMPLANTS, METHOD OF MANUFACTURING THE ADDITIONAL ELEMENT AND FOR ITS FIXING TO A DEVICE, AND HEART VALVE WITH SUCH A SUSPENSION ELEMENT
JPS5146798A (en) * 1974-10-21 1976-04-21 Risaburo Aoki JINKO SHINZOBEN
FR2331320A1 (en) * 1975-11-14 1977-06-10 Gen Atomic Co PROSTHESIS WITH A POROUS REGION CARRIED OUT BY A BUDDIN SPRING AND ASSOCIATED PREPARATION PROCESS
USRE31040E (en) * 1975-04-24 1982-09-28 St. Jude Medical, Inc. Heart valve prosthesis
US4576605A (en) * 1985-03-01 1986-03-18 Nauchno-Issledovatelsky Institut Khirurgii Imeni A.V. Vishnevskogo Cardiac valve prosthesis
US4743253A (en) * 1986-03-04 1988-05-10 Magladry Ross E Suture rings for heart valves and method of securing same to heart valves
US4863460A (en) * 1986-03-04 1989-09-05 Sta-Set Corporation Suture rings for heart valves
US5701931A (en) * 1993-12-17 1997-12-30 Phillips; Trevor J. Water relief valve for a drainage system
US5766240A (en) * 1996-10-28 1998-06-16 Medtronic, Inc. Rotatable suturing ring for prosthetic heart valve
US6139575A (en) * 1999-04-02 2000-10-31 Medtronic, Inc. Hybrid mechanical heart valve prosthesis

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4944517B1 (en) * 1969-03-24 1974-11-28
US4366581A (en) * 1981-09-02 1983-01-04 Medical Incorporated Elliptical suturing cuff
DE202007012817U1 (en) * 2007-09-13 2007-12-20 Siemens & Co. Heilwasser Und Quellenprodukte Des Staatsbades Bad Ems Gmbh & Co. Kg Check valve for a nasal douche

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564023A (en) * 1947-04-14 1951-08-14 Jacob H Miller Reciprocable check valve
US3294116A (en) * 1963-04-25 1966-12-27 Clapets Soc D Non-reflux valves

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2564023A (en) * 1947-04-14 1951-08-14 Jacob H Miller Reciprocable check valve
US3294116A (en) * 1963-04-25 1966-12-27 Clapets Soc D Non-reflux valves

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3526906A (en) * 1965-11-05 1970-09-08 Lorraine Carbone Prosthetic implants made from carbonaceous materials
US3513485A (en) * 1967-04-14 1970-05-26 Temple Univ School Of Medicine Prosthetic heart valve assembly
US3534411A (en) * 1967-10-05 1970-10-20 Donald P Shiley Cloth covered heart valve
US3656185A (en) * 1969-02-04 1972-04-18 Rhone Poulenc Sa Cardiac valvular support prosthesis
DE2313271A1 (en) * 1972-03-17 1973-09-27 Medical Inc ADDITIONAL ELEMENT FOR IMPLANTS, METHOD OF MANUFACTURING THE ADDITIONAL ELEMENT AND FOR ITS FIXING TO A DEVICE, AND HEART VALVE WITH SUCH A SUSPENSION ELEMENT
JPS5146798A (en) * 1974-10-21 1976-04-21 Risaburo Aoki JINKO SHINZOBEN
USRE31040E (en) * 1975-04-24 1982-09-28 St. Jude Medical, Inc. Heart valve prosthesis
FR2331320A1 (en) * 1975-11-14 1977-06-10 Gen Atomic Co PROSTHESIS WITH A POROUS REGION CARRIED OUT BY A BUDDIN SPRING AND ASSOCIATED PREPARATION PROCESS
US4576605A (en) * 1985-03-01 1986-03-18 Nauchno-Issledovatelsky Institut Khirurgii Imeni A.V. Vishnevskogo Cardiac valve prosthesis
US4743253A (en) * 1986-03-04 1988-05-10 Magladry Ross E Suture rings for heart valves and method of securing same to heart valves
US4863460A (en) * 1986-03-04 1989-09-05 Sta-Set Corporation Suture rings for heart valves
US5701931A (en) * 1993-12-17 1997-12-30 Phillips; Trevor J. Water relief valve for a drainage system
US5766240A (en) * 1996-10-28 1998-06-16 Medtronic, Inc. Rotatable suturing ring for prosthetic heart valve
US6139575A (en) * 1999-04-02 2000-10-31 Medtronic, Inc. Hybrid mechanical heart valve prosthesis

Also Published As

Publication number Publication date
SE310235B (en) 1969-04-21
GB1073076A (en) 1967-06-21
DE1500177A1 (en) 1969-05-08

Similar Documents

Publication Publication Date Title
US3396409A (en) Artificial heart valve
US4597767A (en) Split leaflet heart valve
US3689942A (en) Prosthetic heart valve
US5500016A (en) Artificial heart valve
US5078739A (en) Bileaflet heart valve with external leaflets
US4159543A (en) Heart valve prosthesis
US4263680A (en) Prosthetic closure devices to replace the valves in human hearts
US4451937A (en) Heart valve having ear guided occluders
US4308624A (en) Heart valve prosthesis
US3451067A (en) Heart valve
US3589392A (en) Split leaflet check valve for cardiac surgery and the like
US4488318A (en) Prosthetic heart valve
US4328592A (en) Heart valve prosthesis
US5354330A (en) Heart valve prosthesis
US4178639A (en) Two-leaflet heart valve
CA1196152A (en) Edge guided heart valves
US4605408A (en) Artificial cardiac valve with active opening
US4692165A (en) Heart valve
US4114202A (en) Prosthetic valve assembly for use in cardiovascular surgery
US4892540A (en) Two-leaflet prosthetic heart valve
US4218783A (en) Prosthetic closure element for the replacement of the mitral and tricuspid valve in the human heart
US4272854A (en) Bi-leaflet heart valve
US4561129A (en) Low-profile biological bicuspid valve
US4254508A (en) Bileaflet heart valve with improved pivot
US4057857A (en) Heart valve with arcuate occluder